CAH · NYSE · Medical - Distribution

Cardinal Health (CAH)

Distributes pharmaceuticals and manufactures medical products for healthcare providers.

$222.93
vs last close+0.89 (+0.40%)

Cardinal Health is mostly a high-volume middleman, buying medicines and medical supplies and delivering them where care happens. That vast, thin-profit distribution engine still pays the bills, while the company is becoming a broader network of higher-profit services around specialist doctors, home patients and precision treatments.

Item facts: FY2026 · year ended Jun 30, 2026, from filings, earnings calls and company pages.

Judgment weights, not filed revenue

Medicines & specialty care92.4%Medical products5%Home, nuclear & freight~3%

The band summarizes business focus and direction. ~ marks estimates.

6 in detail · 16 more below

  • Pharmaceutical and Specialty Solutions

    · Segment

    The wholesale engine moves ordinary and high-cost medicines at enormous volume for a thin cut. CVS Health alone supplies 28% of companywide sales, so contract retention and drugmakers’ supply terms matter more than product fashion.

    Competes with Pharmaceutical Distribution Services (McKesson) · Brand and Specialty Product Distribution (Cencora)

    In plain English

    Picture a giant grocery wholesaler, but the boxes contain medicines and the customers are pharmacy chains, hospitals and neighborhood drugstores. Cardinal buys the products, owns them while they move through its warehouses, and delivers the right quantities to each customer.

    Most money comes from keeping a small slice of each enormous order. Makers of branded medicines generally pay according to the medicine’s listed wholesale price; lower-cost copies also bring purchase discounts and service fees. The sales pile is huge, but only a thin layer stays with Cardinal, so purchasing terms and reliable delivery do the heavy lifting.

  • Specialty businesses

    · EcosystemRamping

    The faster-growing corner combines costly-medicine delivery with help for drugmakers and specialist practices. It produced more than $50B of FY2026 sales; keeping affiliated doctors and navigating insurers’ payment rules decide how durable that growth is.

    Competes with Oncology & Specialty Distribution (McKesson) · The US Oncology Network (McKesson) · OneOncology network (OneOncology) · Specialty Product Distribution (Cencora)

    In plain English

    These are costly medicines for conditions such as cancer that need more coordination than a routine pharmacy refill. Cardinal gets them from drugmakers to specialist doctors, helps patients gain access and gives manufacturers support for launching and delivering treatments.

    It also runs shared-service networks for independent oncology, digestive-health and urology practices. Those doctors keep treating patients locally while Cardinal supplies medicines, data tools and back-office help. The company earns from the medicine flow and the services around it, making this smaller corner more valuable per sales dollar than basic wholesaling.

  • Global Medical Products and Distribution

    · Segment

    Hospital supplies and procedure kits bring only a small slice of sales but more profit per sales dollar than medicine wholesaling. Revenue barely moved in FY2026; tariffs, recalls, and factory and sourcing efficiency can swing results.

    Competes with Medline Brand and Supply Chain Solutions (Medline) · HALYARD, MediChoice and Medical Action products plus distribution (Owens & Minor)

    In plain English

    A hospital cannot run without a constantly refilled stockroom, much as a restaurant cannot work without a stocked pantry. Cardinal makes or sources everyday medical supplies, packs sets of items needed for procedures, and resells products made by other companies.

    Hospitals and care sites pay for each shipment and for tools that keep shelves organized and show what needs replacing. Cardinal keeps the product markup and service fees. Its own products usually pay better than simple resale, but factory problems, import costs or a recall can quickly eat into that advantage.

  • at-Home Solutions

    · SegmentRamping

    Recurring boxes of diabetes, wound, urology and other supplies generated $4.54B in FY2026 sales. Acquisitions are widening its reach; insurer approval and reliable doorstep delivery determine whether repeat orders stick.

    Competes with Byram Healthcare (Accendra Health) · CCS Medical home delivery (CCS Medical)

    In plain English

    Instead of making a patient visit a medical store every month, at-Home Solutions sends recurring supplies to the doorstep. Edgepark and Advanced Diabetes Supply handle products for diabetes, wounds, bladder care and other long-term needs; another arm supplies organizations that serve patients at home.

    Doctors start many orders, insurers decide what they will cover, and Cardinal checks eligibility, fills the box and arranges delivery. It earns on each shipment. Because the same conditions require repeated refills, keeping patients and processing approvals smoothly can turn one referral into a long run of orders.

  • Nuclear and Precision Health Solutions

    · SegmentRamping

    Local labs prepare short-lived radioactive doses for scans and cancer treatment, a $1.85B FY2026 business. New treatment capacity could lift growth, but a late ingredient or delivery can leave a dose unusable.

    Competes with Radiopharmacy Network (Jubilant Radiopharma) · Supply Chain & Radiopharmacy Services (PharmaLogic)

    In plain English

    Some scans and cancer treatments use a tiny radioactive dose that begins losing usefulness almost as soon as it is made. Cardinal operates local laboratories that prepare each patient’s dose and rush it to hospitals, imaging centers and cancer clinics on schedule.

    The customer pays for a precisely prepared, compliant dose that arrives at the right moment, not merely for the ingredient. Cardinal also manufactures selected treatments for drugmakers and has invested in capacity for newer therapies. Local reach and exact timing create the value; a supply interruption or missed handoff can spoil the product.

  • OptiFreight Logistics

    · Service

    The smallest named line manages health-care shipments rather than owning what is inside the box. FY2026 sales were $405M; its case depends on repeatedly proving savings that customers could not easily get alone.

    Competes with VPL Healthcare Logistics Platform (VPL) · Healthcare Transportation Management (Triose/Cencora)

    In plain English

    Think of OptiFreight as a travel planner for hospital packages. It combines the buying power of many customers, compares delivery routes and rates, tracks each shipment and shows hospitals, pharmacies and laboratories where their delivery spending can shrink.

    Customers pay Cardinal to manage that work, while outside delivery companies still move the parcels and larger loads. The service makes money when its routing tools and negotiated rates save more than the fee costs. If customers cannot see clear savings in the data, they can arrange shipping themselves.

  • Pharmaceutical and Specialty Solutions· SegmentThe wholesale engine moves ordinary and high-cost medicines at enormous volume for a thin cut. CVS Health alone supplies 28% of companywide sales, so contract retention and drugmakers’ supply terms matter more than product fashion.

    The wholesale engine moves ordinary and high-cost medicines at enormous volume for a thin cut. CVS Health alone supplies 28% of companywide sales, so contract retention and drugmakers’ supply terms matter more than product fashion.

    In plain English

    Picture a giant grocery wholesaler, but the boxes contain medicines and the customers are pharmacy chains, hospitals and neighborhood drugstores. Cardinal buys the products, owns them while they move through its warehouses, and delivers the right quantities to each customer.

    Most money comes from keeping a small slice of each enormous order. Makers of branded medicines generally pay according to the medicine’s listed wholesale price; lower-cost copies also bring purchase discounts and service fees. The sales pile is huge, but only a thin layer stays with Cardinal, so purchasing terms and reliable delivery do the heavy lifting.

    Competes with Pharmaceutical Distribution Services (McKesson) · Brand and Specialty Product Distribution (Cencora)

  • Specialty businesses· EcosystemRampingThe faster-growing corner combines costly-medicine delivery with help for drugmakers and specialist practices. It produced more than $50B of FY2026 sales; keeping affiliated doctors and navigating insurers’ payment rules decide how durable that growth is.

    The faster-growing corner combines costly-medicine delivery with help for drugmakers and specialist practices. It produced more than $50B of FY2026 sales; keeping affiliated doctors and navigating insurers’ payment rules decide how durable that growth is.

    In plain English

    These are costly medicines for conditions such as cancer that need more coordination than a routine pharmacy refill. Cardinal gets them from drugmakers to specialist doctors, helps patients gain access and gives manufacturers support for launching and delivering treatments.

    It also runs shared-service networks for independent oncology, digestive-health and urology practices. Those doctors keep treating patients locally while Cardinal supplies medicines, data tools and back-office help. The company earns from the medicine flow and the services around it, making this smaller corner more valuable per sales dollar than basic wholesaling.

    Competes with Oncology & Specialty Distribution (McKesson) · The US Oncology Network (McKesson) · OneOncology network (OneOncology) · Specialty Product Distribution (Cencora)

  • Global Medical Products and Distribution· SegmentHospital supplies and procedure kits bring only a small slice of sales but more profit per sales dollar than medicine wholesaling. Revenue barely moved in FY2026; tariffs, recalls, and factory and sourcing efficiency can swing results.

    Hospital supplies and procedure kits bring only a small slice of sales but more profit per sales dollar than medicine wholesaling. Revenue barely moved in FY2026; tariffs, recalls, and factory and sourcing efficiency can swing results.

    In plain English

    A hospital cannot run without a constantly refilled stockroom, much as a restaurant cannot work without a stocked pantry. Cardinal makes or sources everyday medical supplies, packs sets of items needed for procedures, and resells products made by other companies.

    Hospitals and care sites pay for each shipment and for tools that keep shelves organized and show what needs replacing. Cardinal keeps the product markup and service fees. Its own products usually pay better than simple resale, but factory problems, import costs or a recall can quickly eat into that advantage.

    Competes with Medline Brand and Supply Chain Solutions (Medline) · HALYARD, MediChoice and Medical Action products plus distribution (Owens & Minor)

  • at-Home Solutions· SegmentRampingRecurring boxes of diabetes, wound, urology and other supplies generated $4.54B in FY2026 sales. Acquisitions are widening its reach; insurer approval and reliable doorstep delivery determine whether repeat orders stick.

    Recurring boxes of diabetes, wound, urology and other supplies generated $4.54B in FY2026 sales. Acquisitions are widening its reach; insurer approval and reliable doorstep delivery determine whether repeat orders stick.

    In plain English

    Instead of making a patient visit a medical store every month, at-Home Solutions sends recurring supplies to the doorstep. Edgepark and Advanced Diabetes Supply handle products for diabetes, wounds, bladder care and other long-term needs; another arm supplies organizations that serve patients at home.

    Doctors start many orders, insurers decide what they will cover, and Cardinal checks eligibility, fills the box and arranges delivery. It earns on each shipment. Because the same conditions require repeated refills, keeping patients and processing approvals smoothly can turn one referral into a long run of orders.

    Competes with Byram Healthcare (Accendra Health) · CCS Medical home delivery (CCS Medical)

  • Nuclear and Precision Health Solutions· SegmentRampingLocal labs prepare short-lived radioactive doses for scans and cancer treatment, a $1.85B FY2026 business. New treatment capacity could lift growth, but a late ingredient or delivery can leave a dose unusable.

    Local labs prepare short-lived radioactive doses for scans and cancer treatment, a $1.85B FY2026 business. New treatment capacity could lift growth, but a late ingredient or delivery can leave a dose unusable.

    In plain English

    Some scans and cancer treatments use a tiny radioactive dose that begins losing usefulness almost as soon as it is made. Cardinal operates local laboratories that prepare each patient’s dose and rush it to hospitals, imaging centers and cancer clinics on schedule.

    The customer pays for a precisely prepared, compliant dose that arrives at the right moment, not merely for the ingredient. Cardinal also manufactures selected treatments for drugmakers and has invested in capacity for newer therapies. Local reach and exact timing create the value; a supply interruption or missed handoff can spoil the product.

    Competes with Radiopharmacy Network (Jubilant Radiopharma) · Supply Chain & Radiopharmacy Services (PharmaLogic)

  • OptiFreight Logistics· ServiceThe smallest named line manages health-care shipments rather than owning what is inside the box. FY2026 sales were $405M; its case depends on repeatedly proving savings that customers could not easily get alone.

    The smallest named line manages health-care shipments rather than owning what is inside the box. FY2026 sales were $405M; its case depends on repeatedly proving savings that customers could not easily get alone.

    In plain English

    Think of OptiFreight as a travel planner for hospital packages. It combines the buying power of many customers, compares delivery routes and rates, tracks each shipment and shows hospitals, pharmacies and laboratories where their delivery spending can shrink.

    Customers pay Cardinal to manage that work, while outside delivery companies still move the parcels and larger loads. The service makes money when its routing tools and negotiated rates save more than the fee costs. If customers cannot see clear savings in the data, they can arrange shipping themselves.

    Competes with VPL Healthcare Logistics Platform (VPL) · Healthcare Transportation Management (Triose/Cencora)

Named in filings, launches and programs

  • CVS Health sourcing programsCustomer programRed Oak handles lower-cost medicine purchasing with CVS through June 2029; Averon and IQ cover related complex-medicine and consumer-health buying.
  • Consumer Health Logistics Center and Vantus HQPlatform · RampingIndianapolis automation and a central ordering system aim to move everyday health products through the core distribution network more efficiently.
  • WaveMark SolutionsPlatformTiny radio tags and inventory tools help clinical teams see which supplies are on hand and which need replacing.
  • Edgepark and Advanced Diabetes SupplyBrandThe main at-Home brands deliver recurring medical supplies directly to patients, with Advanced Diabetes Supply added in April 2025.
  • Strive MedicalBrand · RampingA newly acquired home-supply business added to at-Home’s recurring-delivery network.
  • AdaptHealth diabetes businessBrand · AnnouncedA pending addition to the home diabetes-supply network as of August 2026.
  • ContinuCare PathwayPlatform · RampingA digital referral path that moves a care provider’s home-supply order into fulfillment and follow-up.
  • The Specialty Alliance and NavistaEcosystem · RampingShared-service networks for independent digestive-health, urology and oncology practices, built largely through acquisitions.
  • Specialty Networks analyticsPlatformPPS Analytics and SoNaR give specialist practices tools for patient data and research work.
  • Biopharma Solutions stackService · RampingPatient support, packaging and delivery services sold to drugmakers, with management targeting roughly $1B of revenue by FY2028.
  • Xofigo and Lymphoseek programsProduct lineCardinal makes Xofigo under contract and holds U.S. selling rights to Lymphoseek inside its nuclear business.
  • Center for Theranostics Advancement and actinium-225 capacityProduct · AnnouncedNew infrastructure intended to help developers prepare emerging radioactive treatments for cancer.
  • OptiFreight technology suitePlatformTracking, spending tools and route selection form the working system behind the freight service.
  • Kroger distribution renewalCustomer programA renewed long-term agreement to supply Kroger with medicines; its value and exact term were not disclosed.
  • Undisclosed manufacturer programsCustomer program · AnnouncedTwo unnamed gene-therapy launch agreements and an unnamed long-term treatment-results study have no disclosed values.
  • GMPD largest-customer renewalCustomer programA long-term medical-products agreement renewed in FY2026; Cardinal did not name the customer or disclose its value.
  • CVS Health sourcing programsCustomer program

    Red Oak handles lower-cost medicine purchasing with CVS through June 2029; Averon and IQ cover related complex-medicine and consumer-health buying.

  • Consumer Health Logistics Center and Vantus HQPlatform · Ramping

    Indianapolis automation and a central ordering system aim to move everyday health products through the core distribution network more efficiently.

  • WaveMark SolutionsPlatform

    Tiny radio tags and inventory tools help clinical teams see which supplies are on hand and which need replacing.

  • Edgepark and Advanced Diabetes SupplyBrand

    The main at-Home brands deliver recurring medical supplies directly to patients, with Advanced Diabetes Supply added in April 2025.

  • Strive MedicalBrand · Ramping

    A newly acquired home-supply business added to at-Home’s recurring-delivery network.

  • AdaptHealth diabetes businessBrand · Announced

    A pending addition to the home diabetes-supply network as of August 2026.

  • ContinuCare PathwayPlatform · Ramping

    A digital referral path that moves a care provider’s home-supply order into fulfillment and follow-up.

  • The Specialty Alliance and NavistaEcosystem · Ramping

    Shared-service networks for independent digestive-health, urology and oncology practices, built largely through acquisitions.

  • Specialty Networks analyticsPlatform

    PPS Analytics and SoNaR give specialist practices tools for patient data and research work.

  • Biopharma Solutions stackService · Ramping

    Patient support, packaging and delivery services sold to drugmakers, with management targeting roughly $1B of revenue by FY2028.

  • Xofigo and Lymphoseek programsProduct line

    Cardinal makes Xofigo under contract and holds U.S. selling rights to Lymphoseek inside its nuclear business.

  • Center for Theranostics Advancement and actinium-225 capacityProduct · Announced

    New infrastructure intended to help developers prepare emerging radioactive treatments for cancer.

  • OptiFreight technology suitePlatform

    Tracking, spending tools and route selection form the working system behind the freight service.

  • Kroger distribution renewalCustomer program

    A renewed long-term agreement to supply Kroger with medicines; its value and exact term were not disclosed.

  • Undisclosed manufacturer programsCustomer program · Announced

    Two unnamed gene-therapy launch agreements and an unnamed long-term treatment-results study have no disclosed values.

  • GMPD largest-customer renewalCustomer program

    A long-term medical-products agreement renewed in FY2026; Cardinal did not name the customer or disclose its value.